FLT3 D835Y Mutation Detection Kit
£519.00
The geneMAP™ FLT3 D835Y Mutation Detection Kit is specifically designed for the accurate and rapid detection of the FLT3 D835Y mutation in acute myeloid leukemia (AML) patients using allele-specific PCR and multiplex real-time PCR technology. Compatible with FAM and VIC/HEX two-color real-time PCR instruments and CE-IVD certified, this kit offers superior analytical sensitivity and specificity, making it an essential tool for the diagnosis and treatment planning of AML, where FLT3 D835Y mutation impacts the effectiveness of targeted therapies such as fludarabine, azacitidine, and midostaurin.
- Allele Specific PCR: Guarantees high specificity and sensitivity in detecting the FLT3 D835Y mutation.
- Multiplex Real-time PCR Technology: Enables fast and efficient mutation analysis, facilitating timely clinical decision-making.
- Instrument Compatibility: Designed for use with FAM and VIC/HEX two-color real-time PCR instruments, offering versatility in laboratory settings.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring reliability and quality.
- Diagnosis and Treatment Planning for AML: Essential for identifying AML patients with the FLT3 D835Y mutation, informing treatment choices and potential enrollment in clinical trials targeting FLT3 mutations.
- Technology: Utilizes allele-specific and multiplex real-time PCR for efficient and accurate mutation detection.
- Mutation Coverage: Specifically targets the FLT3 D835Y mutation, relevant for a subset of acute myeloid leukemia patients.
- Compatibility: Suitable for use with FAM and VIC/HEX two-color real-time PCR instruments.
- Certification: Carries the CE-IVD mark, indicating compliance with EU regulations for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
